You can find more information about non-SERCA-type Ca2+ -transporting P-ATPase, ATP4 using the following links:

PFID PFID Old Formal Annotation PlasmoDB TDR Targets Subcellular Localization Affecting Drugs
Drug Name PubMed Articles (year of publication)
PF3D7_1211900 PFL0590c non-SERCA-type Ca2+ -transporting P-ATPase, ATP4 PlasmoDB TDR
(+)-SJ733
(1R,3'S,6'R,8a'R)-6''-amino-3-(cyanomethyl)-3'-(hydroxymethyl)-2'',5'-dioxo-2,2',3,3',8',8a'-hexahydro-5'H,7'H-dispiro[indene-1,1'-indolizine-6',3''-indoline]-3-carbonitrile
(2S,3S,4R)-1-(cyclopentanecarbonyl)-4-(hydroxymethyl)-3-[2-(4-methoxyphenyl)phenyl]azetidine-2-carbonitrile
(3S,4S)-N-(3-Cyano-4-fluorophenyl)-1-oxo-3-(3-pyridinyl)-2-(2,2,2-trifluoroethyl)-1,2,3,4-tetrahydro-4-isoquinolinecarboxamide
(8R,9S,10S)-10-[(dimethylamino)methyl]-N-(4-methoxyphenyl)-9-[4-(2-phenylethynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(E)-3-(furan-2-ylmethyl)-8-methoxy-6-(prop-1-en-1-yl)-3,4-dihydro-2H-benzo[e][1,3]oxazine
4-cyano-3-methylisoquinoline
5',7-Dichloro-6-fluoro-3-methyl-2,3,4,9-tetrahydrospiro[β-carboline-1,3'-indol]-2'-ol
5',7-Dichloro-6-fluoro-3-methyl-2,3,4,9-tetrahydrospiro[β-carboline-1,3'-indol]-2'-ol [
5-bromo-3'-(4-chlorophenyl)-5′-phenyl-3′H-spiro[indoline-3,2'- [1,3,4]oxadiazol]-2-one
cipargamin
C-linked phenyl butenonyl c-glycosides with ureidyl, thioureidyl, and sulfonamidyl moieties
Cyclopiazonic acid
cyclosporin A
Essentiality, suggested target
Gnf-pf4492
KAE609
KAF246
Mls000116597
MMV000642
MMV000653
MMV000662
MMV000848
MMV006427
MMV006429
MMV007617
MMV007978
MMV009063
MMV011567
MMV019017
MMV020660
MMV396633
MMV396715
MMV396719
MMV396749
MMV665796
MMV665800
MMV665803
MMV665826
MMV665857
MMV665878
MMV665890
MMV665918
N-(4-(4-chloro-2-fluorophenyl)-1,3-dimethyl-1H-pyrazol5-yl)-2-(2-isopropyl-1H-benzo[d]imidazol-1-yl)acetamid
Naproxen
NITD139
Nitd246
Nitd609
Omeprazole
SJ733
Spiroindolone
Spirotetrahydro-β–carbolines
Vanadate
Expasy - NiceZime View
Brenda - The Comprehensive Enzyme Information System